BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12627519)

  • 1. Cost of chemotherapy-induced thrombocytopenia among patients with lymphoma or solid tumors.
    Elting LS; Cantor SB; Martin CG; Hamblin L; Kurtin D; Rivera E; Vadhan-Raj S; Benjamin RS
    Cancer; 2003 Mar; 97(6):1541-50. PubMed ID: 12627519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis.
    Elting LS; Cooksley C; Chambers M; Cantor SB; Manzullo E; Rubenstein EB
    Cancer; 2003 Oct; 98(7):1531-9. PubMed ID: 14508842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy.
    Cantor SB; Elting LS; Hudson DV; Rubenstein EB
    Cancer; 2003 Jun; 97(12):3099-106. PubMed ID: 12784347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia.
    Vadhan-Raj S; Patel S; Bueso-Ramos C; Folloder J; Papadopolous N; Burgess A; Broemeling LD; Broxmeyer HE; Benjamin RS
    J Clin Oncol; 2003 Aug; 21(16):3158-67. PubMed ID: 12915607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia].
    Wang XY; Feng FY; Song ST; Wang HQ; Zhang MH; Liu J; Liu XY; Xu LG; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):373-6. PubMed ID: 16117903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Bleeding Risk Index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors.
    Elting LS; Martin CG; Kurtin DJ; Cantor SB; Rubenstein EB; Rodriguez S; Kanesan K; Vadhan-Raj S; Benjamin RS
    Cancer; 2002 Jun; 94(12):3252-62. PubMed ID: 12115358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.
    Bennett CL; Calhoun EA
    Oncologist; 2007 Apr; 12(4):478-83. PubMed ID: 17470690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.
    Weycker D; Malin J; Kim J; Barron R; Edelsberg J; Kartashov A; Oster G
    Clin Ther; 2009 May; 31(5):1069-81. PubMed ID: 19539108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia.
    Elting LS; Rubenstein EB; Martin CG; Kurtin D; Rodriguez S; Laiho E; Kanesan K; Cantor SB; Benjamin RS
    J Clin Oncol; 2001 Feb; 19(4):1137-46. PubMed ID: 11181679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness and safety of recombinant human interleukin-11 in the treatment of chemotherapy-induced thrombocytopenia].
    Lei W; Liang J; Chen WG; Ma XZ; Xu M; Du LL
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):542-4. PubMed ID: 17147124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
    Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L.
    Nevo S; Fuller AK; Zahurak ML; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 Sep; 47(9):1700-9. PubMed ID: 17725737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative management of chemotherapeutic-induced thrombocytopenia in women with gynecologic cancers.
    Fanning J; Hilgers RD; Murray KP; Bolt K; Aughenbaugh DM
    Gynecol Oncol; 1995 Nov; 59(2):191-3. PubMed ID: 7590471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
    Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
    Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness and safety of rhIL-11 in the treatment of chemotherapy-induced thrombocytopenia].
    Li L; Xu CG; Wang XW; Guo QS; Sun YH; Sun LM
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):377-9. PubMed ID: 16117904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate.
    Meirow D; Rabinovici J; Katz D; Or R; Shufaro Y; Ben-Yehuda D
    Cancer; 2006 Oct; 107(7):1634-41. PubMed ID: 16944540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy.
    Caggiano V; Weiss RV; Rickert TS; Linde-Zwirble WT
    Cancer; 2005 May; 103(9):1916-24. PubMed ID: 15751024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of rhIL-11 for prevention and treatment of chemotherapy-induced thrombocytopenia].
    Sun XF; Guan ZZ; Huang H; Zhou QH; Yi C; Zhang LJ; Zhu J; Li R; Zhou J; Zhang M; Guo Y
    Ai Zheng; 2002 Aug; 21(8):892-5. PubMed ID: 12478901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.